Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Humana Inc (HUM)

Humana Inc (HUM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 32,554,296
  • Shares Outstanding, K 120,273
  • Annual Sales, $ 117,761 M
  • Annual Income, $ 1,207 M
  • EBIT $ 3,711 M
  • EBITDA $ 4,679 M
  • 60-Month Beta 0.45
  • Price/Sales 0.26
  • Price/Cash Flow 11.23
  • Price/Book 1.73

Options Overview Details

View History
  • Implied Volatility 54.40% (-1.19%)
  • Historical Volatility 34.63%
  • IV Percentile 75%
  • IV Rank 39.68%
  • IV High 95.54% on 04/07/25
  • IV Low 27.33% on 08/20/25
  • Expected Move (DTE 1) 5.36 (2.01%)
  • Put/Call Vol Ratio 1.09
  • Today's Volume 2,809
  • Volume Avg (30-Day) 4,235
  • Put/Call OI Ratio 0.93
  • Today's Open Interest 75,087
  • Open Int (30-Day) 112,577
  • Expected Range 260.93 to 271.65

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -4.01
  • Number of Estimates 11
  • High Estimate -3.53
  • Low Estimate -4.38
  • Prior Year -2.16
  • Growth Rate Est. (year over year) -85.65%

Price Performance

See More
Period Period Low Period High Performance
1-Month
254.38 +4.68%
on 12/26/25
285.61 -6.76%
on 01/15/26
+8.61 (+3.34%)
since 12/22/25
3-Month
221.50 +20.22%
on 11/21/25
299.68 -11.14%
on 10/28/25
-21.43 (-7.45%)
since 10/22/25
52-Week
206.87 +28.72%
on 07/18/25
315.35 -15.56%
on 09/05/25
-18.63 (-6.54%)
since 01/22/25

Most Recent Stories

More News
Headline:Investors who lost money with Humana Inc. (NYSE: HUM) shares should contact the Shareholders Foundation in connection with Lawsuit

SAN DIEGO , Jan. 21, 2026 /PRNewswire/ --The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in Humana Inc shares.

HUM : 266.29 (-1.62%)
What to Expect From Humana’s Next Quarterly Earnings Report

Humana has scheduled to release its fiscal fourth-quarter earnings next month, and analysts project a significant loss.

HUM : 266.29 (-1.62%)
XHS : 111.73 (+1.12%)
$SPX : 6,913.35 (+0.55%)
3 Profitable Stocks to Target This Week

3 Profitable Stocks to Target This Week

EVR : 372.00 (-0.07%)
HUM : 266.29 (-1.62%)
DASH : 207.65 (+0.57%)
Humana Expands Cancer Care for Medicare Advantage Members Through Atlas Oncology Partnership

Eligible Humana Medicare Advantage members in Tennessee and Mississippi now have access to Atlas Oncology Partners’ coordinated oncology care model. The program integrates interdisciplinary...

HUM : 266.29 (-1.62%)
CenterWell Pharmacy to Dispense Obesity Management Medications as Part of New, Employer-Focused Program

Model aims to extend access to FDA-approved obesity management medicines by leveraging the ubiquity of employer benefits

HUM : 266.29 (-1.62%)
Humana Inc. to Release Fourth Quarter 2025 Results on February 11, 2026

Humana Inc. (NYSE: HUM) will release its financial results for the fourth quarter 2025 (4Q25), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on February 11, 2026. The...

HUM : 266.29 (-1.62%)
S&P Futures Tick Lower With U.S. Jobs Data in Focus

March S&P 500 E-Mini futures (ESH26) are trending down -0.12% this morning as caution prevails ahead of the release of U.S. jobs data that could offer clues on the timing of the Federal Reserve’s next...

HUM : 266.29 (-1.62%)
SNDK : 503.44 (+0.43%)
OS : 23.65 (+0.13%)
MBLY : 10.51 (-3.40%)
PLX.FP : 11.680 (-2.67%)
JEF : 63.35 (+2.26%)
ESH26 : 6,945.00s (+0.51%)
ASTS : 116.37 (+12.43%)
VTYX : 13.92 (+0.36%)
DECK : 101.62 (-0.31%)
WDC : 243.29 (+0.57%)
STZ : 160.72 (-1.63%)
1 Safe-and-Steady Stock with Exciting Potential and 2 Facing Headwinds

1 Safe-and-Steady Stock with Exciting Potential and 2 Facing Headwinds

HUM : 266.29 (-1.62%)
MOG.A : 288.46 (-2.88%)
WAT : 400.42 (+0.94%)
Humana, Nurses on Boards Coalition Announce New Partnership to Mentor Emerging Nurses

Humana has announced a new partnership with the national Nurses on Boards Coalition (NOBC) to provide mentors for nursing students. Humana is providing a gift of $110,000...

HUM : 266.29 (-1.62%)
Humana Foundation Report Exposes Epidemic of Loneliness Among Underserved Boys

The Humana Foundation, the philanthropic arm of Humana Inc. for the past 44 years, today announced the publication of its new report, “Strengthening Belonging for Underserved Boys.”...

HUM : 266.29 (-1.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Humana Inc. is a health care plan provider in the United States. The company provides health insurance benefits under Health Maintenance Organization, Private Fee-For-Service and Preferred Provider Organization plans. The company also provides other benefits with specialty products including dental,...

See More

Key Turning Points

3rd Resistance Point 282.06
2nd Resistance Point 278.39
1st Resistance Point 272.34
Last Price 266.29
1st Support Level 262.62
2nd Support Level 258.95
3rd Support Level 252.90

See More

52-Week High 315.35
Fibonacci 61.8% 273.91
Last Price 266.29
Fibonacci 50% 261.11
Fibonacci 38.2% 248.31
52-Week Low 206.87

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar